Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Daily Healthcare St. Lucia.
Press releases published on July 7, 2025
Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option
GlobeNewswire
·
July 7, 2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the release of its Q-FIX KNOTLESS All-Suture Anchor for soft tissue-to-bone fixation indications across multiple joint spaces including Shoulder, Hip, and Foot …
The American Society of Pain and Neuroscience (ASPN) Publishes Consensus Guidelines for the Use of 60-Day Peripheral Nerve Stimulation (PNS) Therapy, Highlighting Strong Clinical Applications for SPR® SPRINT® PNS
GlobeNewswire
·
July 7, 2025
CLEVELAND, July 07, 2025 (GLOBE NEWSWIRE) -- Recently, ASPN published the first clinical guidelines focused specifically on the use of 60-day PNS (SPRINT PNS), offering evidence-based best practice recommendations. It includes positive recommendations for …
Joybird’s Treehouse to Host Free Webinar on Academic Success for Underserved Students
GlobeNewswire
·
July 7, 2025
Dallas, TX , July 07, 2025 (GLOBE NEWSWIRE) -- Joybird’s Treehouse, a culturally responsive education platform founded by veteran educator Joyce Caraway, today announced its second national webinar, “Master the Grade: Keys to Academic Success …
Corza Medical Announces the Launch of the Expanded Onatec Ophthalmic Suture Portfolio
GlobeNewswire
·
July 7, 2025
PARSIPPANY, New Jersey, July 07, 2025 (GLOBE NEWSWIRE) -- Corza Medical, a leading global medical technology company, today announced the launch of its expanded Onatec Ophthalmic Suture Portfolio. This marks a significant extension of the product range, …
Skin Care and Laser Physicians of Beverly Hills Welcomes Double Board-Certified Dermatologist
GlobeNewswire
·
July 7, 2025
LOS ANGELES, July 07, 2025 (GLOBE NEWSWIRE) -- Skin Care and Laser Physicians of Beverly Hills are proud to introduce the newest addition to their esteemed dermatology practice in Los Angeles. Dr. Cory Kosche, a Mohs and Cosmetic Fellowship-Trained …
Immix Biopharma Announces Accelerated NEXICART-2 Clinical Trial Progress in relapsed/refractory AL Amyloidosis
GlobeNewswire
·
July 7, 2025
– National Footprint of NEXICART-2 Trial Sites Expanded – – On track for first Biologics License Application (BLA) approved cell therapy in unaddressed orphan indication – – NEXICART-2 interim results were presented at ASCO 2025 – LOS ANGELES, CA, July …
Nudj Health Appoints Dr. Padmaja Patel as Chief Medical Officer to Advance Lifestyle Medicine Services
GlobeNewswire
·
July 7, 2025
PASADENA, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Nudj Health, the leading AI-powered lifestyle medicine services company, is proud to announce the appointment of Dr. Padmaja Patel as Chief Medical Officer of Lifestyle Medicine Services. In this role, Dr …
Synfini Adds $8.9 Million Discovery Funding to Speed Small Molecule Drug Development
GlobeNewswire
·
July 7, 2025
MENLO PARK, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Synfini, Inc., a trailblazer in AI-driven chemistry automation, today announced a $8.9 million expansion of its round, led by JSL Health Capital and supported by a strong syndicate of early-stage …
SELLAS Life Sciences Appoints Linghua Wang, MD, PhD, to Scientific Advisory Board
GlobeNewswire
·
July 7, 2025
NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
GlobeNewswire
·
July 7, 2025
In an ongoing Phase 1 trial published in Nature Medicine, MB-101 was well-tolerated and 50% of patients achieved stable disease or better with two partial responses and two complete responses lasting 7.5 and 66+ months, respectively Preclinical data …
Ophthalmology Drugs Market to Reach $26.28 Billion by 2030—Vision Care Becomes a Strategic Growth Pillar | MarketsandMarkets™.
GlobeNewswire
·
July 7, 2025
Delray Beach, FL, July 07, 2025 (GLOBE NEWSWIRE) -- What’s powering a $26.28 billion opportunity? The global ophthalmology drugs market, valued at US$18.34 billion in 2024 stood at US$19.52 billion in 2025 and is projected to advance at a resilient CAGR of …
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment
GlobeNewswire
·
July 7, 2025
THE WOODLANDS, TX, July 07, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the next CEO Corner segment has …
Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries
GlobeNewswire
·
July 7, 2025
Includes Conduit’s first composition of matter patent filing for AZD5658 and multiple new combination filings for AZD1656 and AZD5658 Patents derived from AI-led analysis conducted in partnership with Sarborg Limited NAPLES, Fla. and CAMBRIDGE, United …
Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025
GlobeNewswire
·
July 7, 2025
Planned submission of IND application in 2025; Phase 1 clinical trial to follow if IND application approved No new PTSD drug approvals in the U.S. in nearly 25 years; large potential addressable market for SPC-15 worldwide SARASOTA, FL, July 07, 2025 ( …
Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer
GlobeNewswire
·
July 7, 2025
TARPON SPRINGS, Fla., July 7, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor—as …
Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results on August 4, 2025
GlobeNewswire
·
July 7, 2025
MINNEAPOLIS, July 07, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2025 after the close of trading on Monday, August 4. Inspire’s management team will host a …
Collegium Announces $150 Million Share Repurchase Program
GlobeNewswire
·
July 7, 2025
STOUGHTON, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced its Board …
JenaValve's Trilogy™ THV System Procedures Live Broadcast at New York Valves 2025
GlobeNewswire
·
July 7, 2025
IRVINE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the New York Valves 2025 conference, with two live case …
Novel Digital Test Provides Revolutionary Tool to Assess Brain Chemistry
GlobeNewswire
·
July 7, 2025
SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- For the first time, a study shows a digital assessment can provide a scientific measure of acetylcholine – a key brain chemical whose decline signals the progression of cognitive impairment and Alzheimer’s …
Chugai and Gero Enter into Joint Research and License Agreement to Develop Novel Therapies for Age-Related Diseases
GlobeNewswire
·
July 7, 2025
Collaboration to create novel antibody drug candidates using Chugai's proprietary antibody engineering technologies for drug targets identified through Gero's AI-driven human data-first platform Accelerating the creation of innovation by combining Gero's …